Tyrosine Kinase Inhibitor NVP-BGJ398 Functionally Improves FGFR3-related Dwarfism in Mouse Model

Journal of Clinical Investigation - United States
doi 10.1172/jci83926
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

The Bruton’s Tyrosine Kinase Inhibitor Acalabrutinib Protects From Anaphylaxis in a Humanized Mouse Model

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Combined Inhibition of Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3-Kinase (PI3K) P110δ Improves Monocytosis and Splenomegaly in a JMML Mouse Model

Proceedings of IMPRS
2018English

Tyrosine Kinase Inhibitor and Target Therapy

2013English

P11 Tyrosine Kinase Inhibitor Use in Pulmonary Adenocarcinoma

Thorax
PulmonaryRespiratory Medicine
2013English

Tyrosine Kinase Inhibitor–Induced Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2018English

Evaluation of a Tyrosine Kinase Peptide Microarray for Tyrosine Kinase Inhibitor Therapy Selection in Cancer

Experimental & Molecular Medicine
2016English

Ibrutinib: The First Bruton's Tyrosine Kinase Inhibitor

Prescriber
Pharmacology
2018English

Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Tyrosine Kinase Inhibitor Sequencing in Patients With Chronic Myeloid Leukemia

Oncology and Therapy
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy